Aureus Pharma, a leading provider of knowledge management solutions that accelerate life science discovery, has released an exciting new White Paper Using In Silico Compound Profiling to Boost and Optimize Drug Discovery.

Shortly after the release of its extended Predictive Global Pharmacology Platform, including the AurSCOPE Global Pharmacology Space and the AurPROFILER application, the White Paper describes the Aureus’ vision and approach to global compound profiling. The high quality and organizational level of our knowledge bases enables applications that contribute to the successful R&D efforts of our customers.

The Predictive Pharmacology Platform includes quantitative in vitro and in vivo biological activity data for most of the druggable therapeutic targets currently known. In association with the Aureus’ AurProfiler application, the platform provides compound-pharmacology profiles with insights into target or off-target effects, selectivity, cell cytotoxicity and other issues crucial to the discovery process.